2-(4-carbamoylpiperidin-1-yl)acetic acid hydrochloride, 95%, 250mg

N4,N4,N4',N4'-Tetramethyl-[2,2'-bipyridine]-4,4'-diamine, 97%, 1g

Hidroxitolueno butilado, mínimo 99,7 %, para síntesis, 250 g, envase de plástico.

(S)-2-Amino-6-(3-carboxypropanamido)hexanoic acid, 95.0%, 100mg

1-tert-Butyl 4-ethyl 4-(4-fluorobenzyl)piperidine-1,4-dicarboxylate, 98%, 5g

Cloruro de gadolinio hidratado 99,999% 100 g

3-phenylquinoline-2,4-dicarboxylic acid, 95.0%, 500mg

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-6-dihydropyridine-1(2H)-carboxylate, 98.0%, 10g

2-(Difluoromethyl)pyridin-4-amine hydrochloride, 97.0%, 250mg

2-Chlorocyclopentanone (stabilized with HQ + CaCO3)>95.0%(GC)25g

2-(Chloromethyl)-1-methylpiperidine hydrochloride, 97.0%, 10g

Mevastatin, >95%, 100g

Dodecylphosphocholine, 1g